Literature DB >> 33540752

Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy.

Dorothy Pei Shan Chang1, Xue Li Guan1.   

Abstract

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a highly successful intracellular pathogen with the ability to withstand harsh conditions and reside long-term within its host. In the dormant and persistent states, the bacterium tunes its metabolism and is able to resist the actions of antibiotics. One of the main strategies Mtb adopts is through its metabolic versatility-it is able to cometabolize a variety of essential nutrients and direct these nutrients simultaneously to multiple metabolic pathways to facilitate the infection of the host. Mtb further undergo extensive remodeling of its metabolic pathways in response to stress and dormancy. In recent years, advancement in systems biology and its applications have contributed substantially to a more coherent view on the intricate metabolic networks of Mtb. With a more refined appreciation of the roles of metabolism in mycobacterial infection and drug resistance, and the success of drugs targeting metabolism, there is growing interest in further development of anti-TB therapies that target metabolism, including lipid metabolism and oxidative phosphorylation. Here, we will review current knowledge revolving around the versatility of Mtb in remodeling its metabolism during infection and dormancy, with a focus on central carbon metabolism and lipid metabolism.

Entities:  

Keywords:  Mycobacterium tuberculosis; dormancy; infection; metabolism; systems biology; tuberculosis

Year:  2021        PMID: 33540752      PMCID: PMC7913082          DOI: 10.3390/metabo11020088

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  166 in total

Review 1.  Carbon metabolism of intracellular bacteria.

Authors:  Ernesto J Muñoz-Elías; John D McKinney
Journal:  Cell Microbiol       Date:  2006-01       Impact factor: 3.715

Review 2.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

3.  Comparative Metabolomics between Mycobacterium tuberculosis and the MTBVAC Vaccine Candidate.

Authors:  Caridad Díaz; José Pérez Del Palacio; Pedro Luis Valero-Guillén; Patricia Mena García; Irene Pérez; Francisca Vicente; Carlos Martín; Olga Genilloud; Antonio Sánchez Pozo; Jesús Gonzalo-Asensio
Journal:  ACS Infect Dis       Date:  2019-05-30       Impact factor: 5.084

Review 4.  Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.

Authors:  Rebeca Bailo; Apoorva Bhatt; José A Aínsa
Journal:  Biochem Pharmacol       Date:  2015-05-16       Impact factor: 5.858

5.  Metabolic regulation of mycobacterial growth and antibiotic sensitivity.

Authors:  Seung-Hun Baek; Alice H Li; Christopher M Sassetti
Journal:  PLoS Biol       Date:  2011-05-24       Impact factor: 8.029

6.  The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis.

Authors:  Lu Huang; Nicole L Kushner; Monique E Theriault; Davide Pisu; Shumin Tan; Case W McNamara; H Mike Petrassi; David G Russell; Amanda C Brown
Journal:  Front Cell Infect Microbiol       Date:  2018-08-14       Impact factor: 5.293

7.  Path-seq identifies an essential mycolate remodeling program for mycobacterial host adaptation.

Authors:  Eliza Jr Peterson; Rebeca Bailo; Alissa C Rothchild; Mario L Arrieta-Ortiz; Amardeep Kaur; Min Pan; Dat Mai; Abrar A Abidi; Charlotte Cooper; Alan Aderem; Apoorva Bhatt; Nitin S Baliga
Journal:  Mol Syst Biol       Date:  2019-03-04       Impact factor: 11.429

8.  Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis.

Authors:  Jae Jin Lee; Sun-Kyung Lee; Naomi Song; Temitope O Nathan; Benjamin M Swarts; Seok-Yong Eum; Sabine Ehrt; Sang-Nae Cho; Hyungjin Eoh
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

9.  Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics.

Authors:  Frank Vrieling; Sarantos Kostidis; Herman P Spaink; Mariëlle C Haks; Oleg A Mayboroda; Tom H M Ottenhoff; Simone A Joosten
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

10.  An acyl-CoA synthetase in Mycobacterium tuberculosis involved in triacylglycerol accumulation during dormancy.

Authors:  Jaiyanth Daniel; Tatiana Sirakova; Pappachan Kolattukudy
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more
  6 in total

1.  Machine Learning of All Mycobacterium tuberculosis H37Rv RNA-seq Data Reveals a Structured Interplay between Metabolism, Stress Response, and Infection.

Authors:  Reo Yoo; Kevin Rychel; Saugat Poudel; Tahani Al-Bulushi; Yuan Yuan; Siddharth Chauhan; Cameron Lamoureux; Bernhard O Palsson; Anand Sastry
Journal:  mSphere       Date:  2022-03-21       Impact factor: 5.029

2.  The Role of Fatty Acid Metabolism in Drug Tolerance of Mycobacterium tuberculosis.

Authors:  Camila G Quinonez; Jae Jin Lee; Juhyeon Lim; Mark Odell; Christopher P Lawson; Amararachukwu Anyogu; Saki Raheem; Hyungjin Eoh
Journal:  mBio       Date:  2022-01-11       Impact factor: 7.867

Review 3.  Lipid Droplets, the Central Hub Integrating Cell Metabolism and the Immune System.

Authors:  Wei Zhang; Linyong Xu; Ling Zhu; Yifan Liu; Siwei Yang; Mingyi Zhao
Journal:  Front Physiol       Date:  2021-12-03       Impact factor: 4.566

4.  Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis.

Authors:  Soujanya D Yelamanchi; Sumaithangi Thattai Arun Kumar; Archita Mishra; Thottethodi Subrahmanya Keshava Prasad; Avadhesha Surolia
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

5.  Dormancy: There and Back Again.

Authors:  E S Pshennikova; A S Voronina
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

6.  Host- and Age-Dependent Transcriptional Changes in Mycobacterium tuberculosis Cell Envelope Biosynthesis Genes after Exposure to Human Alveolar Lining Fluid.

Authors:  Anna Allué-Guardia; Andreu Garcia-Vilanova; Angélica M Olmo-Fontánez; Jay Peters; Diego J Maselli; Yufeng Wang; Joanne Turner; Larry S Schlesinger; Jordi B Torrelles
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.